You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally Advanced Solid Tumor

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent/Metastatic Gastric Cancer Trial in Seoul (Nivolumab, Paclitaxel)

Completed
  • Recurrent/Metastatic Gastric Cancer
  • Nivolumab, Paclitaxel
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Sep 9, 2022

End of Life, Cancer Trial in Stanford (Lay Health Worker Intervention, Usual Care)

Active, not recruiting
  • End of Life
  • Cancer
  • Lay Health Worker Intervention
  • Usual Care
  • Stanford, California
    Stanford University School of Medicine
Oct 31, 2022

Hiv, Syphilis, Hepatitis B Trial in Bandung City And Bogor District (Continuous quality improvement)

Not yet recruiting
  • Hiv
  • +2 more
  • Continuous quality improvement
  • Bandung City And Bogor District, West Java, Indonesia
    Primary Healthcare Centre in Bandung city and Bogor district
Sep 22, 2023

PIMR and Pulmonary Vascular Disease

Recruiting
  • Pulmonary Hypertension
  • Pulmonary Index of Microcirculatory Resistance
  • +2 more
  • Los Angeles, California
    Ronald Reagan UCLA Medical Center
Apr 24, 2023

COPD Trial (Telehealth Integrated Primary Care (TIPC))

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Telehealth Integrated Primary Care (TIPC)
  • (no location specified)
Nov 15, 2022

Lung Cancer Trial (Weekly symptom monitoring)

Not yet recruiting
  • Lung Cancer
  • Weekly symptom monitoring
  • (no location specified)
Nov 11, 2022

Nasopharyngeal Carcinoma, Neoadjuvant Therapy, PD-1 Inhibitor Trial (PD-1 inhibitor+GP, GP)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • PD-1 inhibitor+GP
  • GP
  • (no location specified)
Jul 1, 2022

Neuroendocrine Carcinoma of the Lung and Thymus Trial in Worldwide (Pasireotide LAR, Everolimus, Pasireotide LAR and Everolimus

Completed
Has Results
  • Neuroendocrine Carcinoma of the Lung and Thymus
  • Pasireotide LAR
  • +2 more
  • Aarhus, Denmark
  • +35 more
Mar 8, 2021

Metastatic Prostate Cancer Trial in Birmingham ([68Ga]PSMA-PET/MRI or PET/CT)

Completed
  • Metastatic Prostate Cancer
  • [68Ga]PSMA-PET/MRI or PET/CT
  • Birmingham, Alabama
    University of Alabama at Birmingham Medical Center
Mar 7, 2022

Parkinson Disease, Sleep Trial in Nashville (Meditation)

Recruiting
  • Parkinson Disease
  • Sleep
  • Meditation
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Apr 14, 2022

Non Small Cell Lung Cancer, Stage I Lung Cancer, Stage Ib Lung Carcinoma Trial in Winston-Salem (Vitamin A Compound, Therapeutic

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Vitamin A Compound
  • Therapeutic Conventional Surgery
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 5, 2023

Epithelial Tumor, Metastatic Cancer Trial in United Kingdom, United States (NG-350A plus Pembrolizumab)

Recruiting
  • Epithelial Tumor
  • Metastatic Cancer
  • NG-350A plus Pembrolizumab
  • Santa Monica, California
  • +3 more
May 4, 2022

Locally Advanced or Metastatic Urothelial Carcinoma Trial in Beijing, Shanghai (Toripalimab Injection, Gemcitabine Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Urothelial Carcinoma
  • Toripalimab Injection
  • +3 more
  • Beijing, China
  • +2 more
Sep 23, 2020

Diffuse Intrinsic Pontine Glioma (DIPG) Trial in United States (Specialized tumor board recommendation, Standard radiation

Completed
  • Diffuse Intrinsic Pontine Glioma (DIPG)
  • Specialized tumor board recommendation
  • Standard radiation therapy
  • San Diego, California
  • +4 more
Nov 2, 2022

Metastatic Colorectal Cancer Trial in Beijing, Tianjin (CMAB009, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +1 more
Oct 18, 2022

Obstacles to Deprescribing Among French Patients Over 75 Years

Recruiting
  • Medication Abuse
  • self-questionnaire
  • Beauvais, France
  • +3 more
Sep 7, 2022

Advanced Cancer Trial in Antwerp, Brussels, Gent (EOS884448)

Completed
  • Advanced Cancer
  • Antwerp, Belgium
  • +3 more
Jun 15, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Pembrolizumab
  • +2 more
  • Anchorage, Alaska
  • +162 more
Aug 23, 2022

Metastatic Anaplastic Thyroid Cancer, Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer Trial in Dallas (Ceritinib)

Withdrawn
  • Metastatic Anaplastic Thyroid Cancer
  • Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 26, 2019

Advanced Lymphoid Leukemia Trial in Worldwide (UCART19 follow-up)

Active, not recruiting
  • Advanced Lymphoid Leukemia
  • UCART19 follow-up
  • Los Angeles, California
  • +15 more
Apr 14, 2022

Hepatocellular Carcinoma Trial in Wuhan (Jiu-wei-zhen-xiao Granule)

Completed
  • Hepatocellular Carcinoma
  • Jiu-wei-zhen-xiao Granule
  • Wuhan, Hubei, China
    Hubei Provincial Hospital of Traditional Chinese Medicine
Apr 7, 2021

Glioblastoma (GBM), DIPG, Brainstem Glioma, Pediatric Trial in Florence (Doxorubicin)

Terminated
  • Glioblastoma (GBM)
  • +7 more
  • Florence, Italy
    Meyer Children's Hospital
Feb 4, 2021

Metastatic Tumor, Renal Cell Carcinoma, Advanced Cancer Trial in Jinan (CD70 CAR-T cells)

Recruiting
  • Metastatic Tumor
  • +2 more
  • CD70 CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jun 26, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck

Active, not recruiting
Has Results
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Washington, District of Columbia
  • +1 more
Mar 25, 2022